Aprikose Pharmaceuticals Private Limited, a active private limited company, was established on 25 April 2016 in Jaipur, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230RJ2016PTC054738. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Muskan Kumawat (Additional Director), Harish Dublad (Director). Past directors included Vikram Jeet. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at P .No. B -2 -A, Surjan Vihar, Nandpuri, Jaipur, Rajasthan, 302006.
U24230RJ2016PTC054738
054738
25 April 2016
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Aprikose Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muskan Kumawat | Additional Director | 11 May 2024 | Current |
| Harish Dublad | Director | 25 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aprikose Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 31.73% increase. The company also saw a substantial improvement in profitability, with a 71.88% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Aprikose Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aprikose Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aprikose Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprikose Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Muskan Kumawat was appointed as a Additional Director was appointed as a Additional Director on 11 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Aprikose Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
The activity Aprikose Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Jaipur. was completed.
Harish Dublad was appointed as a Director was appointed as a Director on 25 Apr 2016 & has been associated with this company since 9 years 7 months . was recorded as a recent event.
Aprikose Pharmaceuticals Private Limited was registered on 25 Apr 2016 with Roc Jaipur & aged 9 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Aprikose Pharmaceuticals Private Limited is U24230RJ2016PTC054738.
Aprikose Pharmaceuticals Private Limited is headquartered at P .No. B -2 -A, Surjan Vihar, Nandpuri, Jaipur, Rajasthan, 302006.
Aprikose Pharmaceuticals Private Limited was incorporated on 25 April 2016.
The current directors of Aprikose Pharmaceuticals Private Limited are
The primary industry of Aprikose Pharmaceuticals Private Limited is Trade.
Aprikose Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aprikose Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aprikose Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX